Javier P. Gisbert

1999–2026 年に発表

別表記
Javier P Gisbert
308
論文数
42,208
被引用数
113
h 指数
294
i10 指数

被引用数

Javier P. Gisbert の年別被引用数1994 年: 被引用 2 件2000 年: 被引用 4 件2001 年: 被引用 3 件2002 年: 被引用 13 件2003 年: 被引用 20 件2004 年: 被引用 38 件2005 年: 被引用 41 件2006 年: 被引用 87 件2007 年: 被引用 138 件2008 年: 被引用 77 件2009 年: 被引用 126 件2010 年: 被引用 164 件2011 年: 被引用 186 件2012 年: 被引用 182 件2013 年: 被引用 309 件2014 年: 被引用 273 件2015 年: 被引用 317 件2016 年: 被引用 334 件2017 年: 被引用 287 件2018 年: 被引用 304 件2019 年: 被引用 1,167 件2020 年: 被引用 1,486 件2021 年: 被引用 1,475 件2022 年: 被引用 1,333 件2023 年: 被引用 1,234 件2024 年: 被引用 2,036 件2025 年: 被引用 879 件2026 年: 被引用 17 件1995〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,914 件、この内訳の 14%中国: 引用元論文 1,309 件、この内訳の 9.5%イタリア: 引用元論文 1,003 件、この内訳の 7.3%イギリス: 引用元論文 825 件、この内訳の 6%スペイン: 引用元論文 710 件、この内訳の 5.2%フランス: 引用元論文 689 件、この内訳の 5%カナダ: 引用元論文 626 件、この内訳の 4.6%ドイツ: 引用元論文 577 件、この内訳の 4.2%オランダ: 引用元論文 421 件、この内訳の 3.1%日本: 引用元論文 386 件、この内訳の 2.8%オーストラリア: 引用元論文 348 件、この内訳の 2.5%ベルギー: 引用元論文 304 件、この内訳の 2.2%
0%14%その他 33.6%

分野

  • Medicine54.3%
  • Biochemistry, Genetics and Molecular Biology37.3%
  • Immunology and Microbiology3.7%
  • Nursing0.8%
  • Agricultural and Biological Sciences0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • その他2.6%

トピック

  • Inflammatory Bowel Disease13.3%
  • Helicobacter pylori-related gastroenterology studies10.3%
  • Microscopic Colitis6.1%
  • Clostridium difficile and Clostridium perfringens research3%
  • Gut microbiota and health2.9%
  • Gastric Cancer Management and Outcomes2.7%
  • その他61.7%

共著者

全論文

検索で開く
  1. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

    著者: , , , , , , , , , , , , , , - Gut 2022 被引用: 1,352

  2. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Selvaggi, Bram Verstockt, Antonino Spinelli, Yves Panís, Glen Doherty - Journal of Crohn s and Colitis 2021 被引用: 1,023

  3. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Maaser, Fernando Magro, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan R. Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino - Journal of Crohn s and Colitis 2019 被引用: 1,344

  4. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

    著者: , , , , , , , , , , , , , , , , , - Gut 2016 被引用: 2,924

  5. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Torsten Kucharzik, Theodore Lytras, Christian Maaser, Fernando Magro, John K. Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, João Sabino, Edoardo Savarino, Laurents Stassen, Joana Torres, Mathieu Uzzan, Stephan R. Vavricka, Bram Verstockt, Oded Zmora - Journal of Crohn s and Colitis 2019 被引用: 1,117

  6. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Selvaggi, Bram Verstockt, Glen Doherty, Tim Raine, Yves Panís - Journal of Crohn s and Colitis 2021 被引用: 528

  7. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

    著者: , , , , , , , , , , - Gastroenterology 2016 被引用: 918

  8. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Siew C. Ng, R. D’Incà, Pia Munkholm - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 191

  9. Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

    著者: , , , , , , , , , , , , - Gut 2012 被引用: 2,259

  10. European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

    著者: , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2014 被引用: 611

  11. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , André D’Hoore, Danny De Looze, Filip Baert, Paul Pattyn, Philippe Zerbib, Frank Zerbib, S Viennot, Jean‐Louis Dupas, P Orsoni, Xavier Hébuterne, Amine Rahili, Matthieu Allez, Yves Panís, Max Reinshagen, Roland Scherer, Andreas Sturm, Wolfgang Kruis, Daniel-Simon Duek, Matti Waterman, Adi Lahat-Zok, Oded Zmora, Hagit Tulchinsky, Yair Edden, Antonino Spinelli, Vito Annese, Imerio Angriman, Gabriele Riegler, Francesco Selvaggi, Bas Oldenburg, Lennard P. L. Gilissen, G Montfort, Mark Löwenberg, Adrianus Willem Bemelman, Raúl Almenara, María Dolores Martín‐Arranz, Mariano García‐Arranz, Javier P. Gisbert, Rosana Palasí, Javier Pérez Gisbert, José Manuel Herrera Justiniano, Ricardo Rada, Ma Teresa Butrón, Ricardo Rada, Antonio López–Sanromán, Joaquín Hinojosa de Val, Amparo Solana, Xavier González-Argenté, C. Martínez Pastor, Héctor Guadalajara, C. Martínez Pastor, Héctor Guadalajara - Gastroenterology 2017 被引用: 485

  12. European Registry onHelicobacter pylorimanagement (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisette G. Capelle, Tomica Milosavljević, Vladimir Milivojević, Lea Veijola, Javier Molina‐Infante, Л. Г. Вологжанина, Galina Fadeenko, Inés Ariño, Giulia Fiorini, Ana Garre, Jesús Garrido, Cristina Fernández, Ignasi Puig, Frédéric Heluwaert, Françis Mégraud, C O'Morain, Javier P. Gisbert - Gut 2020 被引用: 252

  13. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Taku Kobayashi, Paulo Gustavo Kotze, Gaetano Luglio, Christian Maaser, Gordon W. Moran, Nurulamin M Noor, Konstantinos Papamichael, Georgios Peros, Cathérine Reenaers, Giuseppe Sica, Rotem Sigall Boneh, Stephan R. Vavricka, Henit Yanai, Pär Myrelid, Michel Adamina, Tim Raine - Journal of Crohn s and Colitis 2024 被引用: 315

  14. Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity

    著者: , , , , , , , , , , , , , , , , , , , , , , - Immunity 2019 被引用: 223

  15. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis

    著者: , , , , , , , , - Gastroenterology 2021 被引用: 181

  16. Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease

    著者: , , - Microorganisms 2021 被引用: 180

  17. Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice

    著者: , - Journal of Crohn s and Colitis 2019 被引用: 278

  18. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease

    著者: , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2011 被引用: 653

  19. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Lémann - The Lancet 2012 被引用: 642

  20. Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg)

    著者: , , , , , , , , , , , , , , , , , , , , , , - Antibiotics 2021 被引用: 111

  21. Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review

    著者: , - The American Journal of Gastroenterology 2009 被引用: 663

  22. Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed

    著者: , , , - Alimentary Pharmacology & Therapeutics 2015 被引用: 314

  23. Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luis Hernández, Alfredo J. Lucendo, Lucía Márquez, Olga Merino-Ochoa, Francisco José Rancel, Carlos Taxonera, Antonio López Sanromán, Saioa Rubio Iturria, Eugeni Domènech, Javier P. Gisbert - Journal of Crohn s and Colitis 2020 被引用: 102

  24. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diz-Lois M Palomares, Gionata Fiorino, J M Benítez, Mariabeatrice Principi, Timna Naftali, Carlos Taxonera, G. Mantzaris, Ladislava Sebkova, Beatriz Iade, Donata Lissner, Ferrer I Bradley, Lopez-San A Roman, Ignacio Marín‐Jiménez, Olga Merino, M Sierra, Manuel Van Domselaar, Flavio Caprioli, Iván Guerra, Paula Peixe, Marta Piqueras, Iago Rodríguez–Lago, Yolanda Ber, Karen van Hoeve, P Torres, Marta Gravito‐Soares, Ditte Rudbeck-Resdal, Ottavia Bartolo, Armando Peixoto, Grégory Martin, Alessandro Armuzzi, A Garre, María G. Donday, Martín F J de Carpi, Javier P. Gisbert - The American Journal of Gastroenterology 2018 被引用: 171